AI startups Niramai and Wadhwani AI highlight challenges in India’s public healthcare

AI’s role in addressing public healthcare gaps

At TechSparks 2026, experts highlighted how AI is being leveraged to bridge critical gaps in India’s public healthcare system. Startups are focusing on remote monitoring, early disease detection, and decision-making tools for frontline health workers, according to YourStory. These solutions aim to address constraints in infrastructure, accessibility, and affordability, particularly in rural and underserved areas.

Key challenges for AI adoption

Integrating AI into India’s public health infrastructure presents three major challenges: clinical validation, system integration, and the patience capital required for scaling. According to YourStory, innovators must design solutions that account for real-world constraints such as inconsistent internet connectivity, incomplete data, and the need for multilingual and culturally adaptable tools.

One of the most significant barriers is the tendency to prioritise rapid product development over rigorous clinical validation. AI models developed in controlled laboratory settings often fail to deliver reliable results in real-world healthcare environments. YourStory noted that technologies must be tested not only in hospitals but also in rural areas where diagnostic infrastructure is limited.

Integration and scalability strategies

Wadhwani AI has adopted a hands-on approach to integration by embedding teams in 17 state health offices. These teams, consisting of five to seven members each, work directly within government systems to facilitate adoption and adapt solutions to local workflows. YourStory reported that understanding both central and state government systems is critical for companies aiming to operate in public health.

Shekhar Sivasubramanian of Wadhwani AI emphasised the scale of the challenge, stating that India has around 150,000 primary health centres. Innovators must be prepared to work at this scale, which requires sustained financial resources and perseverance. Without these, companies risk reaching only a fraction of their potential impact before disengaging.

Affordability and global expansion

Affordability, accessibility, acceptability, and accuracy are the four pillars driving AI adoption in public health, according to YourStory. Niramai Health Analytix, which uses thermal imaging and AI for non-invasive breast cancer screening, aims to reduce the cost of its solution to below Rs 50 per screening at scale. The startup has already screened around seven lakh women in India.

Niramai has also expanded its technology to six centres in the US after receiving FDA approval. This underscores the potential for Indian healthcare innovators to pursue international opportunities while addressing local needs. However, regulatory requirements, reimbursement structures, and pricing models vary across markets, requiring tailored deployment strategies.

Investor and ecosystem considerations

Debraj Banerjee of Fundamentum Frontier Advisors highlighted the complexities investors must assess when backing AI healthcare startups. These include navigating regulatory approvals, securing financing, and understanding the challenges of customer acquisition. Deep-tech companies, in particular, require an ecosystem that supports their journey from product development to commercialisation, according to YourStory.

The broader challenge lies not only in developing advanced technology but also in building the systems necessary to deliver it to end-users. This includes training healthcare workers, adapting solutions to existing workflows, and collaborating with government officials who ultimately implement these tools.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

This discussion at TechSparks 2026 underscores the hard truths of deploying AI in India’s public healthcare system. For founders and operators, the takeaway is clear: clinical validation and real-world testing are non-negotiable. The success of startups like Niramai and Wadhwani AI shows that solutions must be designed for the constraints of India’s infrastructure—low connectivity, fragmented data, and diverse linguistic and cultural contexts.

The patience capital required is another critical lesson. Scaling in public health is a long game, often involving years of engagement with government systems. Investors, too, need to recalibrate expectations; returns may not be immediate, but the impact—and eventual commercial opportunity—can be substantial.

For Indian startups eyeing global markets, Niramai’s FDA approval and US expansion demonstrate that local innovation can meet international standards. However, founders must be prepared to adapt their models to different regulatory and reimbursement landscapes. The key is balancing localisation with global ambition.

Related on Lazyfounder

• More health news